$HRZN
Horizon Technology Finance Corp Stock $hrzn

$hrzn Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000143774924023921 Filed on July 30, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$12.21M	$13.27M
YoY Change	-30.36%	8.81%
Cost Of Revenue	$11.92M	$11.85M
YoY Change	6.34%	4.67%
Gross Profit	$8.083M	-$8.217M
YoY Change	-170.84%	-1036.94%
Gross Profit Margin	66.2%	-61.92%
Selling, General & Admin	$432.0K	$559.0K
YoY Change	10.77%	2.38%
% of Gross Profit	5.34%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$432.0K	$559.0K
YoY Change	8.0%	2.38%
Operating Profit	$7.651M	-$8.776M
YoY Change	-164.78%	-2751.36%
Interest Expense	$7.945M	$7.940M
YoY Change	11.79%	10.6%
% of Operating Profit	103.84%
Other Income/Expense, Net
YoY Change
Pretax Income	$7.651M	-$8.776M
YoY Change	-164.84%	-2751.36%
Income Tax	$373.0K	$357.0K
% Of Pretax Income	4.88%
Net Earnings	$7.278M	-$9.133M
YoY Change	-160.75%	-6108.55%
Net Earnings / Revenue	59.61%	-68.82%
Basic Earnings Per Share	$0.32	$0.36
Diluted Earnings Per Share	$0.20	-$0.26
COMMON SHARES
Basic Shares Outstanding	36.06M	35.02M
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$83.38M	$113.7M
YoY Change	76.28%	126.13%
Cash & Equivalents	$86.65M	$116.9M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$99.17M	$130.4M
YoY Change	61.52%	100.12%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$687.3M	$650.1M
YoY Change	-6.1%	-9.13%
Other Assets
YoY Change
Total Long-Term Assets	$693.9M	$657.0M
YoY Change	-5.7%	-9.03%
TOTAL ASSETS
Total Short-Term Assets	$99.17M	$130.4M
Total Long-Term Assets	$693.9M	$657.0M
Total Assets	$793.1M	$787.4M
YoY Change	-0.52%	0.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$3.072M	$3.011M
YoY Change	-0.9%	36.86%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$70.28M	$72.87M
YoY Change	6.01%	69.73%
Total Short-Term Liabilities	$86.86M	$88.75M
YoY Change	6.57%	55.96%
LONG-TERM LIABILITIES
Long-Term Debt	$363.7M	$369.9M
YoY Change	-1.49%	-1.39%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$363.7M	$369.9M
YoY Change	-1.49%	-1.39%
TOTAL LIABILITIES
Total Short-Term Liabilities	$86.86M	$88.75M
Total Long-Term Liabilities	$363.7M	$369.9M
Total Liabilities	$450.5M	$458.6M
YoY Change	-0.03%	6.17%
SHAREHOLDERS EQUITY
Retained Earnings	-$157.9M	-$152.6M
YoY Change	50.08%	85.71%
Common Stock	$42.00K	$40.00K
YoY Change	20.0%	17.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$342.5M	$328.8M
YoY Change
Total Liabilities & Shareholders Equity	$793.1M	$787.4M
YoY Change	-0.52%	0.0%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	$7.278M	-$9.133M
YoY Change	-160.75%	-6108.55%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$28.26M	$54.29M
YoY Change	19.08%	-1089.95%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.969M	-8.748M
YoY Change	-109.52%	-172.18%
NET CHANGE
Cash From Operating Activities	-28.26M	54.29M
Cash From Investing Activities
Cash From Financing Activities	-1.969M	-8.748M
Net Change In Cash	-30.23M	45.54M
YoY Change	891.02%	586.38%
FREE CASH FLOW
Cash From Operating Activities	-$28.26M	$54.29M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	hrzn	Investment Income Attributable To Noncash Paidinkind Interest Percent InvestmentIncomeAttributableToNoncashPaidinkindInterestPercent	0.014	pure
CY2023Q2	hrzn	Investment Income Attributable To Noncash Paidinkind Interest Percent InvestmentIncomeAttributableToNoncashPaidinkindInterestPercent	0.034	pure
	hrzn	Investment Income Attributable To Noncash Paidinkind Interest Percent InvestmentIncomeAttributableToNoncashPaidinkindInterestPercent	0.033	pure
	hrzn	Investment Income Attributable To Noncash Paidinkind Interest Percent InvestmentIncomeAttributableToNoncashPaidinkindInterestPercent	0.038	pure
CY2024Q2	hrzn	Investment Nonaccrual Income Not Received In Cash Percent InvestmentNonaccrualIncomeNotReceivedInCashPercent	0.066	pure
CY2023Q2	hrzn	Investment Nonaccrual Income Not Received In Cash Percent InvestmentNonaccrualIncomeNotReceivedInCashPercent	0.031	pure
	hrzn	Investment Nonaccrual Income Not Received In Cash Percent InvestmentNonaccrualIncomeNotReceivedInCashPercent	0.067	pure
	hrzn	Investment Nonaccrual Income Not Received In Cash Percent InvestmentNonaccrualIncomeNotReceivedInCashPercent	0.047	pure
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q2	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	725430000	usd
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	759182000	usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36211280
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33534854
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36043815
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33367389
CY2024Q2	hrzn	Investment Owned Nav Percent InvestmentOwnedNavPercent	1.967	pure
CY2023Q4	hrzn	Investment Owned Nav Percent InvestmentOwnedNavPercent	2.189	pure
	hrzn	Investments Nonaccrual Interest Income InvestmentsNonaccrualInterestIncome	0	usd
	hrzn	Investments Nonaccrual Interest Income InvestmentsNonaccrualInterestIncome	0	usd
CY2024Q2	hrzn	Investments Nonaccrual Interest Income InvestmentsNonaccrualInterestIncome	0	usd
CY2023Q2	hrzn	Investments Nonaccrual Interest Income InvestmentsNonaccrualInterestIncome	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
	us-gaap	Open Tax Year OpenTaxYear	2024 2023 2022 2021
CY2024Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0
CY2023Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-2114934
	dei	Entity Address Address Line1 EntityAddressAddressLine1	312 Farmington Avenue
	dei	Entity Address City Or Town EntityAddressCityOrTown	Farmington
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CT
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	06032
	dei	City Area Code CityAreaCode	860
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	36059675
CY2024Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	646862000	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	709085000	usd
CY2024Q2	us-gaap	Cash Cash	81333000	usd
CY2023Q4	us-gaap	Cash Cash	46630000	usd
CY2024Q2	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	32320000	usd
CY2023Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	26450000	usd
CY2024Q2	us-gaap	Restricted Investments RestrictedInvestments	3221000	usd
CY2023Q4	us-gaap	Restricted Investments RestrictedInvestments	2642000	usd
CY2024Q2	us-gaap	Interest Receivable InterestReceivable	16733000	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	13926000	usd
CY2024Q2	us-gaap	Other Assets OtherAssets	6936000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	3623000	usd
CY2024Q2	us-gaap	Assets Assets	787405000	usd
CY2023Q4	us-gaap	Assets Assets	802356000	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	442744000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	462235000	usd
CY2024Q2	us-gaap	Distribution Payable DistributionPayable	11894000	usd
CY2023Q4	us-gaap	Distribution Payable DistributionPayable	11011000	usd
CY2024Q2	us-gaap	Management Fee Payable ManagementFeePayable	978000	usd
CY2023Q4	us-gaap	Management Fee Payable ManagementFeePayable	1052000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	3011000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	4077000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	458627000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	478375000	usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	40000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	36000	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	481349000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	450949000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-152611000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-127004000	usd
CY2024Q2	hrzn	Net Assets NetAssets	328778000	usd
CY2023Q4	hrzn	Net Assets NetAssets	323981000	usd
CY2024Q2	hrzn	Liabilities And Net Assets LiabilitiesAndNetAssets	787405000	usd
CY2023Q4	hrzn	Liabilities And Net Assets LiabilitiesAndNetAssets	802356000	usd
CY2024Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	9.12
CY2023Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	9.71
CY2024Q2	hrzn	Investment Company Investment Income Net InvestmentCompanyInvestmentIncomeNet	25678000	usd
CY2023Q2	hrzn	Investment Company Investment Income Net InvestmentCompanyInvestmentIncomeNet	28117000	usd
	hrzn	Investment Company Investment Income Net InvestmentCompanyInvestmentIncomeNet	51807000	usd
	hrzn	Investment Company Investment Income Net InvestmentCompanyInvestmentIncomeNet	56154000	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	7940000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	7179000	usd
	us-gaap	Interest Expense InterestExpense	16101000	usd
	us-gaap	Interest Expense InterestExpense	14299000	usd
CY2024Q2	us-gaap	Management Fee Expense ManagementFeeExpense	3027000	usd
CY2023Q2	us-gaap	Management Fee Expense ManagementFeeExpense	3207000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	6189000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	6408000	usd
CY2024Q2	hrzn	Performance Based Incentive Fee PerformanceBasedIncentiveFee	0	usd
CY2023Q2	hrzn	Performance Based Incentive Fee PerformanceBasedIncentiveFee	118000	usd
	hrzn	Performance Based Incentive Fee PerformanceBasedIncentiveFee	295000	usd
	hrzn	Performance Based Incentive Fee PerformanceBasedIncentiveFee	3094000	usd
CY2024Q2	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	426000	usd
CY2023Q2	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	368000	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	859000	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	808000	usd
CY2024Q2	us-gaap	Professional Fees ProfessionalFees	455000	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	447000	usd
	us-gaap	Professional Fees ProfessionalFees	1120000	usd
	us-gaap	Professional Fees ProfessionalFees	1106000	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	559000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	546000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	987000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	992000	usd
CY2024Q2	us-gaap	Costs And Expenses CostsAndExpenses	12407000	usd
CY2023Q2	us-gaap	Costs And Expenses CostsAndExpenses	11865000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	25551000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	26707000	usd
CY2024Q2	us-gaap	Net Investment Income NetInvestmentIncome	13271000	usd
CY2023Q2	us-gaap	Net Investment Income NetInvestmentIncome	16252000	usd
	us-gaap	Net Investment Income NetInvestmentIncome	26256000	usd
	us-gaap	Net Investment Income NetInvestmentIncome	29447000	usd
CY2024Q2	us-gaap	Investment Income Operating Tax Expense Benefit InvestmentIncomeOperatingTaxExpenseBenefit	357000	usd
CY2023Q2	us-gaap	Investment Income Operating Tax Expense Benefit InvestmentIncomeOperatingTaxExpenseBenefit	179000	usd
	us-gaap	Investment Income Operating Tax Expense Benefit InvestmentIncomeOperatingTaxExpenseBenefit	736000	usd
	us-gaap	Investment Income Operating Tax Expense Benefit InvestmentIncomeOperatingTaxExpenseBenefit	363000	usd
CY2024Q2	us-gaap	Investment Income Operating After Expense And Tax InvestmentIncomeOperatingAfterExpenseAndTax	12914000	usd
CY2023Q2	us-gaap	Investment Income Operating After Expense And Tax InvestmentIncomeOperatingAfterExpenseAndTax	16073000	usd
	us-gaap	Investment Income Operating After Expense And Tax InvestmentIncomeOperatingAfterExpenseAndTax	25520000	usd
	us-gaap	Investment Income Operating After Expense And Tax InvestmentIncomeOperatingAfterExpenseAndTax	29084000	usd
CY2024Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	2464000	usd
CY2023Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-16529000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	2472000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-16697000	usd
CY2024Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-24511000	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	608000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-28471000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-6929000	usd
CY2024Q2	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	-22047000	usd
CY2023Q2	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	-15921000	usd
	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	-25999000	usd
	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	-23626000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-9133000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	152000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-479000	usd
	us-gaap	Net Income Loss NetIncomeLoss	5458000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.36
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.54
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.74
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1
CY2024Q2	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	-0.26
CY2023Q2	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	0.01
	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	-0.01
	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	0.19
CY2024Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.33
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.33
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.71
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.66
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35434761
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29747290
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34507252
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28987948
CY2023Q1	us-gaap	Assets Net AssetsNet	321683000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	44002000	usd
CY2023Q2	us-gaap	Investment Income Operating After Expense And Tax InvestmentIncomeOperatingAfterExpenseAndTax	16073000	usd
CY2023Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-16529000	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	608000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	251000	usd
CY2023Q2	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	10669000	usd
CY2023Q2	us-gaap	Assets Net AssetsNet	355419000	usd
CY2024Q1	us-gaap	Assets Net AssetsNet	332121000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	17138000	usd
CY2024Q2	us-gaap	Investment Income Operating After Expense And Tax InvestmentIncomeOperatingAfterExpenseAndTax	12914000	usd
CY2024Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	2464000	usd
CY2024Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-24511000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	675000	usd
CY2024Q2	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	12023000	usd
CY2024Q2	us-gaap	Assets Net AssetsNet	328778000	usd
CY2022Q4	us-gaap	Assets Net AssetsNet	318448000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	51176000	usd
	us-gaap	Investment Income Operating After Expense And Tax InvestmentIncomeOperatingAfterExpenseAndTax	29084000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-16697000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-6929000	usd
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	469000	usd
	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	20132000	usd
CY2023Q2	us-gaap	Assets Net AssetsNet	355419000	usd
CY2023Q4	us-gaap	Assets Net AssetsNet	323981000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	29110000	usd
	us-gaap	Investment Income Operating After Expense And Tax InvestmentIncomeOperatingAfterExpenseAndTax	25520000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	2472000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-28471000	usd
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	1294000	usd
	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	25128000	usd
CY2024Q2	us-gaap	Assets Net AssetsNet	328778000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-479000	usd
	us-gaap	Net Income Loss NetIncomeLoss	5458000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	814000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	950000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	2472000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-16697000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-28471000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-6929000	usd
	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	35384000	usd
	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	87553000	usd
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Securities Operating Activities ProceedsFromMaturitiesPrepaymentsAndCallsOfSecuritiesOperatingActivities	76056000	usd
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Securities Operating Activities ProceedsFromMaturitiesPrepaymentsAndCallsOfSecuritiesOperatingActivities	64496000	usd
	us-gaap	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind	1737000	usd
	us-gaap	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind	2154000	usd
	us-gaap	Proceeds From Sale Of Securities Operating Activities ProceedsFromSaleOfSecuritiesOperatingActivities	88000	usd
	us-gaap	Proceeds From Sale Of Securities Operating Activities ProceedsFromSaleOfSecuritiesOperatingActivities	8506000	usd
	hrzn	Equity Received In Settlement Of Fee Income EquityReceivedInSettlementOfFeeIncome	0	usd
	hrzn	Equity Received In Settlement Of Fee Income EquityReceivedInSettlementOfFeeIncome	-89000	usd
	hrzn	Warrants Received In Settlement Of Fee Income WarrantsReceivedInSettlementOfFeeIncome	-359000	usd
	hrzn	Warrants Received In Settlement Of Fee Income WarrantsReceivedInSettlementOfFeeIncome	0	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	982000	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-65000	usd
	hrzn	Increase Decrease In Endofterm Payments IncreaseDecreaseInEndoftermPayments	1825000	usd
	hrzn	Increase Decrease In Endofterm Payments IncreaseDecreaseInEndoftermPayments	1291000	usd
	hrzn	Increase Decrease In Unearned Income IncreaseDecreaseInUnearnedIncome	2429000	usd
	hrzn	Increase Decrease In Unearned Income IncreaseDecreaseInUnearnedIncome	2291000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	292000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	717000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-1066000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-484000	usd
	us-gaap	Increase Decrease In Management Fee Payable IncreaseDecreaseInManagementFeePayable	-74000	usd
	us-gaap	Increase Decrease In Management Fee Payable IncreaseDecreaseInManagementFeePayable	-2000	usd
	us-gaap	Increase Decrease In Incentive Fee Payable IncreaseDecreaseInIncentiveFeePayable	0	usd
	us-gaap	Increase Decrease In Incentive Fee Payable IncreaseDecreaseInIncentiveFeePayable	-1274000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	58330000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7246000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	29110000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	51175000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	50000000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	30000000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	70000000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	35000000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	3337000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	729000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	22951000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	18229000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-17178000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	15452000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	41152000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	22698000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	75722000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	30466000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	116874000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	53164000	usd
	us-gaap	Interest Paid Net InterestPaidNet	15237000	usd
	us-gaap	Interest Paid Net InterestPaidNet	13409000	usd
	hrzn	Refinanced Debt Investment Balances RefinancedDebtInvestmentBalances	11250000	usd
	hrzn	Refinanced Debt Investment Balances RefinancedDebtInvestmentBalances	0	usd
	hrzn	Warrant Investments Received And Recorded As Unearned Income WarrantInvestmentsReceivedAndRecordedAsUnearnedIncome	858000	usd
	hrzn	Warrant Investments Received And Recorded As Unearned Income WarrantInvestmentsReceivedAndRecordedAsUnearnedIncome	656000	usd
CY2024Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	11894000	usd
CY2023Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	10592000	usd
	hrzn	Endofterm Payments Receivable Noncash Transaction EndoftermPaymentsReceivableNoncashTransaction	13641000	usd
	hrzn	Endofterm Payments Receivable Noncash Transaction EndoftermPaymentsReceivableNoncashTransaction	11074000	usd
	us-gaap	Other Significant Noncash Transaction Value Of Consideration Received1 OtherSignificantNoncashTransactionValueOfConsiderationReceived1	7983000	usd
	us-gaap	Other Significant Noncash Transaction Value Of Consideration Received1 OtherSignificantNoncashTransactionValueOfConsiderationReceived1	7182000	usd
CY2024Q2	us-gaap	Cash Cash	81333000	usd
CY2023Q2	us-gaap	Cash Cash	24395000	usd
CY2024Q2	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	32320000	usd
CY2023Q2	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	25865000	usd
CY2024Q2	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	3221000	usd
CY2023Q2	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	2904000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	116874000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53164000	usd
CY2024Q2	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	725430000	usd
CY2024Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	646862000	usd
CY2024Q2	hrzn	Percentage Of Nonqualifying Assets On A Cost Basis PercentageOfNonqualifyingAssetsOnACostBasis	0.048	pure
CY2024Q2	hrzn	Percentage Of Nonqualifying Assets On A Fair Value Basis PercentageOfNonqualifyingAssetsOnAFairValueBasis	0.014	pure
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	759182000	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	709085000	usd
CY2023Q4	hrzn	Percentage Of Nonqualifying Assets On A Cost Basis PercentageOfNonqualifyingAssetsOnACostBasis	0.047	pure
CY2023Q4	hrzn	Percentage Of Nonqualifying Assets On A Fair Value Basis PercentageOfNonqualifyingAssetsOnAFairValueBasis	0.027	pure
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 11pt;"><b><i>Use of estimates</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:18pt;">In preparing the consolidated financial statements in accordance with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities, as of the date of the balance sheet and income and expenses for the period. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the valuation of investments.</p>
CY2024Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	8300000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5800000	usd
CY2024Q2	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	6000000	usd
CY2023Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	5200000	usd
CY2024Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	400000	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	500000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	800000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	900000	usd
CY2024Q2	hrzn	Federal Excise Tax Percent FederalExciseTaxPercent	0.04	pure
CY2024Q2	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	400000	usd
CY2023Q2	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	200000	usd
	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	700000	usd
	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	400000	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2024Q2	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	5000000	usd
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	167465
	hrzn	Stock Repurchased During Period Per Share StockRepurchasedDuringPeriodPerShare	11.22
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1900000	usd
CY2024Q2	us-gaap	Management Fee Expense ManagementFeeExpense	3000000	usd
CY2023Q2	us-gaap	Management Fee Expense ManagementFeeExpense	3200000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	6200000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	6400000	usd
CY2024Q2	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	725430000	usd
CY2024Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	646862000	usd
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	759182000	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	709085000	usd
CY2024Q2	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	725430000	usd
CY2024Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	646862000	usd
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	759182000	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	709085000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	709946000	usd
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	12065000	usd
CY2024Q2	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Warrants And Equity Received FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetWarrantsAndEquityReceived	1089000	usd
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	56413000	usd
CY2024Q2	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Payment Inkind Interest FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPaymentInkindInterest	355000	usd
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	47000	usd
CY2024Q2	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Realized Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings	2660000	usd
CY2024Q2	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Appreciation Depreciation Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAppreciationDepreciationIncludedInEarnings	-24165000	usd
CY2024Q2	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Between Investments FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersBetweenInvestments	0	usd
CY2024Q2	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Other Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetOtherPeriodIncreaseDecrease	742000	usd
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	646232000	usd
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	713407000	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	40545000	usd
CY2023Q2	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Warrants And Equity Received FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetWarrantsAndEquityReceived	604000	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	24740000	usd
CY2023Q2	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Payment Inkind Interest FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPaymentInkindInterest	950000	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	1986000	usd
CY2023Q2	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Realized Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings	-16512000	usd
CY2023Q2	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Appreciation Depreciation Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAppreciationDepreciationIncludedInEarnings	205000	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	-111000	usd
CY2023Q2	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Between Investments FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersBetweenInvestments	0	usd
CY2023Q2	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Other Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetOtherPeriodIncreaseDecrease	882000	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	713244000	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	100000	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	706858000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	35384000	usd
	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Warrants And Equity Received FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetWarrantsAndEquityReceived	1217000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	76056000	usd
	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Payment Inkind Interest FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPaymentInkindInterest	1737000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	88000	usd
	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Realized Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings	2681000	usd
	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Appreciation Depreciation Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAppreciationDepreciationIncludedInEarnings	-27068000	usd
	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Between Investments FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersBetweenInvestments	0	usd
	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Other Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetOtherPeriodIncreaseDecrease	1567000	usd
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	646232000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	716319000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	87553000	usd
	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Warrants And Equity Received FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetWarrantsAndEquityReceived	745000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	64496000	usd
	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Payment Inkind Interest FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPaymentInkindInterest	2154000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	8506000	usd
	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Realized Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings	-16646000	usd
	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Appreciation Depreciation Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAppreciationDepreciationIncludedInEarnings	-5662000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	-111000	usd
	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Between Investments FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersBetweenInvestments	0	usd
	hrzn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Other Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetOtherPeriodIncreaseDecrease	1894000	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	713244000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	100000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0	usd
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	715000000	usd
CY2024Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	446000000	usd
CY2024Q2	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	269000000	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	615000000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	466000000	usd
CY2023Q4	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	149000000	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	3256000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	3765000	usd
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	715000000	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	442744000	usd
CY2024Q2	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	269000000	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	615000000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	462235000	usd
CY2023Q4	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	149000000	usd
CY2024Q2	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Face Amount Liability FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability	137500000	usd
CY2024Q2	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Amount Liability FairValueDisclosureOffbalanceSheetRisksAmountLiability	1474000	usd
CY2023Q4	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Face Amount Liability FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability	180500000	usd
CY2023Q4	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Amount Liability FairValueDisclosureOffbalanceSheetRisksAmountLiability	2033000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.71
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	16320000	usd
	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	73548
	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	874000	usd
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.37
CY2023	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	41881000	usd
CY2023	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	145743
CY2023	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	1833000	usd
CY2024Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.38
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.36
CY2024Q2	us-gaap	Earnings Per Share Basic Undistributed EarningsPerShareBasicUndistributed	1.28
CY2023Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	9.71
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	11.47
	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.74
	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	1
	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.07
	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.58
	hrzn	Investment Company Investment Depreciation Appreciation Per Share InvestmentCompanyInvestmentDepreciationAppreciationPerShare	-0.82
	hrzn	Investment Company Investment Depreciation Appreciation Per Share InvestmentCompanyInvestmentDepreciationAppreciationPerShare	-0.23
	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	-0.01
	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	0.19
	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.71
	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.66
	hrzn	Investment Company Distribution To Shareholders Per Share Net Investment Income InvestmentCompanyDistributionToShareholdersPerShareNetInvestmentIncome	-0.71
	hrzn	Investment Company Distribution To Shareholders Per Share Net Investment Income InvestmentCompanyDistributionToShareholdersPerShareNetInvestmentIncome	-0.66
CY2024Q2	hrzn	Investment Company Distribution To Shareholders Per Share Net Realized Gain On Investments InvestmentCompanyDistributionToShareholdersPerShareNetRealizedGainOnInvestments	0
CY2023Q2	hrzn	Investment Company Distribution To Shareholders Per Share Net Realized Gain On Investments InvestmentCompanyDistributionToShareholdersPerShareNetRealizedGainOnInvestments	0
	us-gaap	Investment Company Tax Return Of Capital Distribution Per Share InvestmentCompanyTaxReturnOfCapitalDistributionPerShare	0
	us-gaap	Investment Company Tax Return Of Capital Distribution Per Share InvestmentCompanyTaxReturnOfCapitalDistributionPerShare	0
	hrzn	Investment Company Distribution To Shareholders Per Share Other InvestmentCompanyDistributionToShareholdersPerShareOther	0.13
	hrzn	Investment Company Distribution To Shareholders Per Share Other InvestmentCompanyDistributionToShareholdersPerShareOther	0.07
CY2024Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	9.12
CY2023Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	11.07
CY2023Q4	us-gaap	Share Price SharePrice	13.17
CY2022Q4	us-gaap	Share Price SharePrice	11.6
CY2024Q2	us-gaap	Share Price SharePrice	12.04
CY2023Q2	us-gaap	Share Price SharePrice	12.08
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	-0.032	pure
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.098	pure
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36043815
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32096259
	us-gaap	Investment Company Expense Ratio Excluding Incentive Fee InvestmentCompanyExpenseRatioExcludingIncentiveFee	0.156	pure
	us-gaap	Investment Company Expense Ratio Excluding Incentive Fee InvestmentCompanyExpenseRatioExcludingIncentiveFee	0.142	pure
	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0	pure
	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0.019	pure
	us-gaap	Investment Company Expense Ratio Including Incentive Fee InvestmentCompanyExpenseRatioIncludingIncentiveFee	0.156	pure
	us-gaap	Investment Company Expense Ratio Including Incentive Fee InvestmentCompanyExpenseRatioIncludingIncentiveFee	0.161	pure
	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.155	pure
	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.175	pure
CY2024Q2	hrzn	Net Assets NetAssets	328778000	usd
CY2023Q2	hrzn	Net Assets NetAssets	355419000	usd
CY2024Q2	hrzn	Average Net Assets AverageNetAssets	328293000	usd
CY2023Q2	hrzn	Average Net Assets AverageNetAssets	331850000	usd
	hrzn	Investment Company Average Debt Per Share InvestmentCompanyAverageDebtPerShare	13.03
	hrzn	Investment Company Average Debt Per Share InvestmentCompanyAverageDebtPerShare	15.11
	hrzn	Investment Company Portfolio Turnover Ratio InvestmentCompanyPortfolioTurnoverRatio	0.054	pure
	hrzn	Investment Company Portfolio Turnover Ratio InvestmentCompanyPortfolioTurnoverRatio	0.076	pure

Files In Submission

Name	View Source	Status
0001437749-24-023921-index-headers.html	Edgar Link	pending
0001437749-24-023921-index.html	Edgar Link	pending
0001437749-24-023921.txt	Edgar Link	pending
0001437749-24-023921-xbrl.zip	Edgar Link	pending
ex_672582.htm	Edgar Link	pending
ex_672583.htm	Edgar Link	pending
ex_672584.htm	Edgar Link	pending
ex_672585.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hrzn-20240630.xsd	Edgar Link	pending
hrzn20240630_10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
hrzn-20240630_cal.xml	Edgar Link	unprocessable
hrzn-20240630_def.xml	Edgar Link	unprocessable
hrzn-20240630_lab.xml	Edgar Link	unprocessable
hrzn-20240630_pre.xml	Edgar Link	unprocessable
hrzn20240630_10q_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HRZN
Horizon Technology Finance Corp Stock $hrzn

2024 Q3 Form 10-Q Financial Statement

#000143774924023921 Filed on July 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HRZN Horizon Technology Finance Corp Stock $hrzn

2024 Q3 Form 10-Q Financial Statement

#000143774924023921 Filed on July 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HRZN
Horizon Technology Finance Corp Stock $hrzn